AQR Capital Management’s Applied Therapeutics APLT Stock Holding History

AQR Capital Management’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,413	Closed	-$1.34K	–	3744
2025 Q4	$1.34K	Sell	13,413 -96,274	-88%	-$61.2K	﹤0.01%	3562
2025 Q3	$66.3K	Sell	109,687 -177,228	-62%	-$83.5K	﹤0.01%	3405
2025 Q2	$89.3K	Sell	286,915 -285,396	-50%	-$110K	﹤0.01%	3197
2025 Q1	$280K	Buy	+572,311	New	+$337K	﹤0.01%	2721
2024 Q4	–	Sell	-218,518	Closed	-$1.86M	–	2869
2024 Q3	$1.86M	Buy	+218,518	New	+$1.29M	﹤0.01%	1543
2022 Q3	–	Sell	-13,907	Closed	-$13K	–	2188
2022 Q2	$13K	Sell	13,907 -71,157	-84%	-$117K	﹤0.01%	2171
2022 Q1	$179K	Buy	+85,064	New	+$228K	﹤0.01%	2084

AQR Capital Management's APLT Position: Q1 2026 in Review

AQR Capital Management sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 13,413 shares — an estimated $1.34K sold.

AQR Capital Management first reported a position in APLT in Q1 2022 and held it in 7 quarters. The position peaked at $1.86M in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

AQR Capital Management reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
AQR Capital Management sold 13,413 Applied Therapeutics shares in Q1 2026, an estimated $1.34K.
AQR Capital Management first reported a position in Applied Therapeutics in Q1 2022 and held it in 7 quarters.
AQR Capital Management's Applied Therapeutics position peaked at $1.86M in Q3 2024.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.